A case of focal segmental glomerulosclerosis (FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis

Japanese Journal of Nephrology

Volumn 44, Issue 8, 2002, Pages 806-812

  Takaki, Akinobu ^a   Nakatsuka, Atsuko ^b   Satou, Chikage ^b   Iwata, Yasuyoshi ^b   Ikeda, Hiroshi ^a   Fukushima, Masaki ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b NONE

Author keywords

Chronic hepatitis B; Focal segmental glomerulosclerosis(FSGS); Low density lipoprotein (LDL) apheresis; Nephrotic syndrome; Prednisolone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; CERIVASTATIN; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; PREDNISOLONE; STEROID;

ADULT; APHERESIS; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROTIC SYNDROME; PROTEINURIA; STEROID THERAPY; URINARY EXCRETION; VIRUS HEPATITIS;

ANTI-INFLAMMATORY AGENTS; BLOOD COMPONENT REMOVAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS B, CHRONIC; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDNISOLONE; TREATMENT OUTCOME;

EID: 0036965068     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Combes B, Stastny P, Shorey J, Engenbrodt EH, Barrera A, Hull AR, Carter NW. Glomerulonephritis with deposition of australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971; 2: 234-6.
2. Lin CY. Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int 1991; 40 (Suppl 35): S46-53.
3. Levy M, Chen N. Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int 1991; 40(Suppl 35): S24-33.
4. Lai KN, Lai FM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int 1991; 40(Suppl 35): S40-5.
5. Lai KK, Philip KTL, Lui SF, Au TC, Tam JSL, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324(21): 1457-63.
6. Takekoshi Y, Tochimaru H, Nagata Y, Itami N. Immunopathogenetic mechanism of hepatitis B virus-related glomerulopathy. Kidney Int 1991; 40(Suppl 35): S34-9.
7. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994; 8: 11-4.
8. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995; 47: 225-30.
9. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, DI Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995; 109: 540-6.
10. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of cortico-steroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenemia. Nephron 1990; 54: 12-7.
11. Lai NL, Ho RTH, Tam JS, Lai FM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis. Kidney Int 1996; 50: 1965-77.
12. Dienstag JL, Perrilo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-61.
13. Taskapan H, Oymak O, Dogukan A, Ozbakir O, Utas C. Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 2000 54(2): 161-3.
14. Olson JL, Schwartz MM. The Nephrotic Syndrome: Minimal change disease, focal segmental glomerulosclerosis, and miscellaneous causes. In: Jennete JC, Olson JL, Schwartz MM, Silva FG(eds)Heptinstall's pathology of the kidney. 5th ed. Philadelphia: Lippincott Raven Publishers, 1998: 187-257.
15. Yagisawa T, Toma H, Tanabe K, Ishikawa N, Tokumoto N, Iguchi Y, Goya N, Nakazawa H, Takahashi K, Ota K. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporine era. Am J Nephrol 1997; 17: 440-4.
16. Cote PJ, Korba BE, Steinberg H, Ramirez-Mejia C, Baldwin B, Hornbuckle WE, Tennant BC, Gerin JL. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol 1991; 146: 3138-44.
17. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y, The Kansai FGS LDL apheresis treatment(KFLAT) study group. Significantly rapid relief from steroidresistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron 2001; 89: 408-15.
18. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30(2): 567-72. 813-816